| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 04/01/2004 | US20040063643 Bombesin antagonists |
| 04/01/2004 | US20040060127 E.g., p-(3-(3-trimethylsilanylpropoxy)-1-pyrrolidyl)-phenylamine |
| 04/01/2004 | DE10243666A1 Dithiocarbaminsäureester Dithiocarbaminsäureester |
| 04/01/2004 | CA2768674A1 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
| 04/01/2004 | CA2499701A1 Pyrrole derivatives as antimycobacterial compounds |
| 04/01/2004 | CA2499490A1 Amide and sulfonamide ligands for the estrogen receptor |
| 04/01/2004 | CA2499426A1 Process for preparing n-hydroxylamine compounds |
| 04/01/2004 | CA2498335A1 4-pyrrolidino-phenyl-benzyl ether derivatives |
| 03/31/2004 | EP1401918A2 Biodegradable poly(beta-amino esters) and uses thereof |
| 03/31/2004 | EP1401828A1 N-formyl hydroxylamine compounds as inhibitors of pdf |
| 03/31/2004 | EP1401824A2 Aromatic hydroxamic acid derivatives useful as hdac inhibitors |
| 03/31/2004 | EP1401821A1 Novel phenylalkyl diamine and amide analogs |
| 03/31/2004 | EP1401817A1 Isoquinoline compounds having antiinfective activity |
| 03/31/2004 | EP1401811A1 Method for producing pyrrolidones |
| 03/31/2004 | EP1401810A1 Compounds having prolyl oligopeptidase inhibitory activity, methods for their preparation and their use |
| 03/31/2004 | EP1401809A1 Tryptase inhibitors |
| 03/31/2004 | EP1370258A4 Peptide deformylase inhibitors |
| 03/31/2004 | EP1363623A4 Peptide deformylase inhibitors |
| 03/31/2004 | CN1486172A Primary intermediates for oxidative coloration of hair |
| 03/31/2004 | CN1143675C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 03/30/2004 | US6713635 As chemical intermediates used for the preparation of s-alpha-ethyl-2-oxo-1-pyrrolidine acetamide |
| 03/30/2004 | US6713634 Pyrroloazepine derivatives |
| 03/30/2004 | US6713603 Adjusted nucleotide sequences for use as antisense tools in genetic engineering |
| 03/30/2004 | US6713504 Antifungal molecule 2-(3,4-dimethyl-2,5-dihydro-1H-pyrrol-2-yl)-1-methylethyl pentanoate |
| 03/30/2004 | US6713503 1-(2,4-dimethyl-phenyl)-2,4-dihydroxy-3-(4-methyl-benzoyl)-5-oxo-2,5 -dihydro-1h-pyrrole-2-carboxylic acid methyl ester |
| 03/30/2004 | US6713502 Anti-infectives |
| 03/30/2004 | US6713492 N-acyloxylated cycloalkyl compounds, composition containing the same and methods of use therefor |
| 03/30/2004 | US6713467 Anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and metastasis inhibitors in treating cancer |
| 03/30/2004 | US6713059 Antibodies raised against immunogenic conjugates of gram-negative bacterial autoinducer molecules |
| 03/30/2004 | CA2278687C 5-aroylnaphthalene derivatives |
| 03/25/2004 | WO2004024991A1 Organic salts and their use as reagents in electrochemical reactions |
| 03/25/2004 | WO2004024939A2 Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof |
| 03/25/2004 | WO2004024702A1 Novel carboxamide compounds having an mch-antagonistic effect, medicaments containing said compounds, and methods for the production thereof |
| 03/25/2004 | WO2004024686A1 Biological low-molecular weight derivatives |
| 03/25/2004 | WO2004024685A1 Novel dipeptide compound and medical use tehreof |
| 03/25/2004 | WO2004024681A2 Novel compounds comprising a thiocarbonyl-sulfanyl group, which can be used for the radical synthesis of alpha-perfluoroalkylamines |
| 03/25/2004 | WO2004024679A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 03/25/2004 | WO2004024143A1 Medicinal composition |
| 03/25/2004 | WO2004024139A1 Melanin extinguisher |
| 03/25/2004 | WO2003084941A3 Hydroxamic acid derivatives |
| 03/25/2004 | WO2003082260A3 Tuberculosis treatment using pleuromutilin derivatives |
| 03/25/2004 | WO2003048106A3 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof |
| 03/25/2004 | WO2002096871A8 Allylmercaptocaptopril compounds and uses thereof |
| 03/25/2004 | US20040059149 Method for the synthesis of compounds of formula 1 and derivatives thereof |
| 03/25/2004 | US20040059129 2,5-bisphenyl-delta1-pyrroline derivative are chromatographed on a stationary chiral silica gel phase in presence of an eluent or mixture as liquid phase |
| 03/25/2004 | US20040058968 Antiinflammatory agents; autoimmune diseases; antiarthritic agents |
| 03/25/2004 | US20040058960 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 03/25/2004 | US20040058932 Novel piperazine derivatives |
| 03/25/2004 | US20040058820 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis |
| 03/25/2004 | DE10243201A1 New N-acyl-aminoacid N-(succinimidyl-carbonyl-alkyl)-amide compounds, are broad-spectrum antibacterial agents useful in human or veterinary medicine |
| 03/25/2004 | CA2499606A1 Biological low-molecular-weight derivatives |
| 03/25/2004 | CA2497003A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 03/25/2004 | CA2496563A1 New carboxamide compounds having mch-antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture |
| 03/24/2004 | EP1400516A1 Substituted anilide derivatives, intermediates thereof, agricultural and horticultural chemicals, and their usage |
| 03/24/2004 | EP1400508A1 Dithiocarbamic acid ester |
| 03/24/2004 | EP1399433A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 03/24/2004 | EP1399431A2 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 03/24/2004 | EP1399421A1 Substituted imidates as pesticidal agents |
| 03/24/2004 | EP1399420A2 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 03/24/2004 | EP1399163A2 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection |
| 03/24/2004 | EP1399159A1 4-substituted-1-(arylmethylidene)thiosemicarbazide, 4-substituted-1-(arylcarbonyl)thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/24/2004 | EP1399154A1 3-fluoro-pyrrolidines as antidiabetic agents |
| 03/24/2004 | EP1399146A1 Novel compounds and compositions as cathepsin inhibitors |
| 03/24/2004 | EP1214296B1 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 03/24/2004 | EP1161232B1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists |
| 03/24/2004 | EP1082110B1 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 03/24/2004 | CN1484637A Pyrrolcarboxamides and pyrrolcarbothioamides and their agrochemical uses |
| 03/24/2004 | CN1484527A Medicines for treatment and prevention of neurogenic pain |
| 03/24/2004 | CN1142920C Quinazoline derivatives and pharmaceutical compositions containing them and preparation process and use |
| 03/24/2004 | CN1142911C Compounds with growth hormone releasing properties |
| 03/24/2004 | CN1142793C Epoxy-steroidal aldosterone antagonist and angiotensin 2 antagonist combination therapy for treatment of congestive heart failure |
| 03/23/2004 | US6710186 Conformationally-restricted; analogous to poly(proline) ii helical structure |
| 03/23/2004 | US6710179 Compounds with analgesic effect |
| 03/23/2004 | US6710089 Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 03/23/2004 | US6710061 Selective serine protease or dual-serine protease inhibitors of factor xa and tryptase |
| 03/23/2004 | US6710040 Fluorinated cyclic amides as dipeptidyl peptidase IV inhibitors |
| 03/23/2004 | CA2263319C Quinazoline derivatives and pharmaceutical compositions containing them |
| 03/18/2004 | WO2004022536A1 New heterocyclic amide compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 03/18/2004 | WO2004022533A1 Novel vinyl carboxylic acid derivatives and their therapeutical use |
| 03/18/2004 | WO2004022529A2 Diarylurea derivatives and their use as chloride channel blockers |
| 03/18/2004 | WO2004022525A1 Amide derivatives and their use as chloride channel blockers |
| 03/18/2004 | WO2004022523A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 03/18/2004 | WO2004022053A1 Atorvastatin calcium form vi or hydrates thereof |
| 03/18/2004 | WO2003099266A3 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 03/18/2004 | WO2003087094A3 Pyrrolidinium derivatives as antagonists of m3 muscarinic receptors |
| 03/18/2004 | WO2003086563A3 Diabetes imaging probes |
| 03/18/2004 | WO2003079975A3 Process for the manufacture of optically active 3-substituted lactams by asymmetric hydrogenation of 3-alkylidenelactams |
| 03/18/2004 | WO2003035615A3 Tyrosine kinase inhibitors |
| 03/18/2004 | WO2003035614A3 Tyrosine kinase inhibitors |
| 03/18/2004 | WO2003018535A3 Novel aminobenzoephenones |
| 03/18/2004 | US20040054194 Cyclization, deacylation nding amide in presence of diluent; insecticide for agriculture |
| 03/18/2004 | US20040054193 Crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1) |
| 03/18/2004 | US20040054184 Preservative for organs, synthetic blood |
| 03/18/2004 | US20040054009 Useful for potentiating glutamate receptor function in a mammal and therefore useful for treating wide variety of conditions such as psychiatric and neurological disorders |
| 03/18/2004 | US20040053987 Bis-heterocyclic compounds with antitumour and chemosensitising activity |
| 03/18/2004 | US20040053983 1, 2, 4-tribsubstituted benzenes as inhibitors of 15-lipoxygenase |
| 03/18/2004 | US20040053981 Such as 2-(5(6)-nitro-2-benzimidazoyl)-5-(4-nitrophenyl)furan; fluorescent quantitative analysis; for treatment/prevention of cancer |
| 03/18/2004 | US20040053953 Treatment of chemokine mediated diseases |
| 03/18/2004 | US20040053933 Ligands of melanocortin receptors and compositions and methods related thereto |
| 03/18/2004 | US20040053917 Reacting cyanophenyl-4-sulfonylchloride with a piperidine-4-oxo in presence of ethylene glycol to form an intermediate, reducing cyano group, followed by amidation, then reacting with an amine to form sulfonamide end |